Internet Explorer is no longer supported by Microsoft. To browse the NIHR site please use a modern, secure browser like Google Chrome, Mozilla Firefox, or Microsoft Edge.

NICE Rolling Call (i4i)

Contents

Published: 03 September 2024

Version: 1.0 September 2024

Print this document

The Invention for Innovation (i4i) Programme is accepting Stage 1 applications to this funding opportunity. The programme is interested in receiving applications to meet recommendations in research identified in NICE guidance that has been published or updated in the last 5 years.

Proposals must be within the remit of the Invention for Innovation (i4i) Programme. This call is also open in the Efficacy and Mechanism Evaluation (EME), Health Technology Assessment (HTA)Health and Social Care Delivery Research (HSDR) Public Health Research (PHR), NIHR Programme Grants for Applied Research (PGfAR), Research for Patient Benefit (RfPB) and Research Programme for Social Care (RPSC) programmes for proposals which fall within the remit of those programmes – applicants should apply directly to the relevant programme.

In order to apply you will need to carefully review the:

The i4i PDA application supporting information provides further details on:

  • eligibility
  • collaboration and team expertise
  • timescales
  • funding limits
  • guidance on applying

All proposals submitted must fall within the scope of the i4i Programme.

All primary research projects are expected to establish a programme appointed Study Steering Committee and it is important that you read the Research Governance Guidance before completing your application. Costs incurred by this committee should be included in the budget as appropriate.

Timescales

Any changes to these dates will be emailed to all Lead Applicants with an application in progress. 

  • Stage 1 deadline: 5th December 2024
  • notification of out of remit/non-competitive decision if unsuccessful: February 2025
  • notification of Stage 1 shortlisting decision: February 2025
  • Stage 2 writing window: February 2025 - 2nd April 2025
  • notification of Stage 2 funding decision: Earliest July 2025